| __timestamp | Arrowhead Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 91733000 |
| Thursday, January 1, 2015 | 34718089 | 87644000 |
| Friday, January 1, 2016 | 40998209 | 92365000 |
| Sunday, January 1, 2017 | 32022880 | 85656000 |
| Monday, January 1, 2018 | 19110051 | 88196000 |
| Tuesday, January 1, 2019 | 26556257 | 89971000 |
| Wednesday, January 1, 2020 | 52275890 | 93413000 |
| Friday, January 1, 2021 | 80981000 | 91355000 |
| Saturday, January 1, 2022 | 124431000 | 113676000 |
| Sunday, January 1, 2023 | 90932000 | 198366000 |
| Monday, January 1, 2024 | 98761000 | 218935000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting strategies in this area. From 2014 to 2024, Taro consistently maintained higher SG&A expenses, peaking at over 218% of Arrowhead's costs in 2024. However, Arrowhead's expenses surged by approximately 305% from 2014 to 2022, indicating a strategic shift. Despite Taro's higher absolute expenses, their steady trend suggests a controlled approach, while Arrowhead's fluctuating costs reflect dynamic growth and investment strategies. This analysis provides a fascinating insight into how two industry leaders navigate financial management, offering valuable lessons for investors and competitors alike.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.